Image

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Investigating Investigational Medication PET Imaging for Cancer Diagnosis

Recruiting
18-80 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the use of [18F]FPyQCP PET imaging for various cancer types, including colorectal cancer, gastric cancer, pancreatic ductal adenocarcinoma, invasive lobular breast cancer, and epithelial ovarian cancer.

The study evaluates the safety and diagnostic capabilities of [18F]FPyQCP PET imaging. It focuses on understanding how well this imaging method can identify these cancer types.

  • Who can participate: Participants must be between 18 and 79 years old and able to give informed consent. Key eligibility includes having a confirmed diagnosis of certain cancers such as colorectal, gastric, or pancreatic cancer.
  • Study details: Participants will undergo investigational medication PET imaging to evaluate cancer presence.
Print
Study details
    Colorectal Cancer
    Epithelial Ovarian Cancer
    Gastric Cancer
    Invasive Lobular Breast Carcinoma
    Pancreatic Ductal Adenocarcinoma

NCT07432633

Blue Earth Diagnostics

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.